Country Experiences

The Country Experiences section of the Injectables Toolkit includes case studies and other publications describing country experiences with programmatic topics included in the toolkit. These include:

  • Assessing demand for injectables and feasibility of introducing injectables in a particular country;
  • Expanding access to injectables using a variety of service delivery models;
  • Removing barriers to use of injectables.

These experiences will inform health policy makers, program managers, and service providers of the strategies, challenges, and lessons learned from initiatives that address the use of injectables within family planning programs.

Many reports are available that discuss the implementation of community-based distribution of injectables, as this approach has been found to be a safe and effective means for increasing accessibility of injectables and decreasing unmet need for family planning. To view these materials, please visit the Country Experiences section of the Community-Based Access to Injectable Contraceptives Toolkit.

Please click on the links below to access injectable materials from a particular country.

Multi-country         Bangladesh         Ethiopia         India         Kenya         Malawi        

Nigeria         Pakistan         Senegal         South Africa         Uganda

Do you have a comment about this section or would you like to suggest a new resource or management topic? Please share your feedback by emailing us at toolkits@k4health.org or posting on our discussion board.

Multi-country

Bangladesh

Ethiopia

India

    2009 | USAID | 58 pp
    To generate demand for DMPA as a safe and effective contraceptive choice and increase its availability through partnership with commercial and social marketing agencies, the United States Agency for International Development (USAID) launched the DIMPA program to expand the choi
    2007 | PSP-One India | 16
    The DiMPA is a network of private OB/GYNs and general practitioners trained to provide quality family planning services with a focus on the depot-medroxyprogesterone acetate (DMPA) 3-month injectable in 45 cities of Uttar Pradesh, Uttarakhand and Jharkhand. The goals of the network are: to create awareness about DMPA as a safe and effective method of contraception; to increase access to and use of DMPA through the private health sector by establishing a network; and to promote correct use and compliance through sustained high quality of service.

Kenya

Malawi

Nigeria

Pakistan

Senegal

South Africa

    2007 | International Family Planning Perspectives | 33 (2) :66-74
    Abstract: Research examining hormonal injectable contraceptive continuation has focused on clients' intentional discontinuation. Little attention, however, has been paid to unintentional discontinuation due to providers' management of clients who would like to continue use but arrive late for their scheduled reinjections. A cross-sectional survey of 1,042 continuing injectable clients at 10 public clinics was conducted in South Africa's Western and Eastern Cape provinces.

Uganda

    2011 | International Perspectives on Sexual and Reproductive Health | 37(1):24-9
    Abstract CONTEXT: Informal drug shops are the first line of health care in many poor countries. In Uganda, these facilities commonly sell and administer the injectable contraceptive depot medroxyprogesterone acetate (DMPA), even though they are prohibited by law from selling any injectable drugs. It is important to understand drug shop operators' current practices and their potential to provide DMPA to hard-to-reach populations.